United States · FDA National Drug Code directory
sodium nitroprusside
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 14335-131_1f875458-09fa-7330-e063-6394a90aac33
- Product NDC
- 14335-131
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- sodium nitroprusside
- Labeler
- Hainan Poly Pharm. Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240813
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM NITROPRUSSIDE — 50 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (14335-131-01) / 2 mL in 1 VIAL · 14335-131-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →